Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness
- PMID: 7629504
- PMCID: PMC2192121
- DOI: 10.1084/jem.182.2.439
Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness
Abstract
Major histocompatibility complex (MHC) class I molecules are cell-surface proteins that present peptides to CD8+ T cells. These peptides are mostly derived from endogenously synthesized protein. Recombinant, soluble MHC class I molecules were produced, purified, and loaded homogeneously with synthetic peptide. These MHC-peptide complexes were used to activate a T cell hybridoma. While monomers of MHC-peptide bound to the T cell, they showed no stimulatory activity. Dimers fully triggered the T cell hybridoma to secrete interleukin 2. This response was followed by a state in which the T cell was refractory to restimulation as a result of defective signal transduction through the T cell receptor.
Similar articles
-
CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.J Immunol. 2006 Feb 1;176(3):1498-505. doi: 10.4049/jimmunol.176.3.1498. J Immunol. 2006. PMID: 16424178
-
Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC.Cell. 1989 Jan 13;56(1):47-55. doi: 10.1016/0092-8674(89)90982-3. Cell. 1989. PMID: 2783386
-
Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.Eur J Immunol. 1991 Dec;21(12):2963-70. doi: 10.1002/eji.1830211210. Eur J Immunol. 1991. PMID: 1660811
-
Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor.Immunol Today. 2000 Dec;21(12):630-6. doi: 10.1016/s0167-5699(00)01750-3. Immunol Today. 2000. PMID: 11114424 Review.
-
The role of T-cell receptor dimerization in T-cell activation.Immunol Today. 1999 Dec;20(12):568-76. doi: 10.1016/s0167-5699(99)01543-1. Immunol Today. 1999. PMID: 10562708 Review.
Cited by
-
Antigen-specific therapeutic approaches in Type 1 diabetes.Cold Spring Harb Perspect Med. 2012 Feb;2(2):a007773. doi: 10.1101/cshperspect.a007773. Cold Spring Harb Perspect Med. 2012. PMID: 22355799 Free PMC article. Review.
-
Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13729-34. doi: 10.1073/pnas.212515299. Epub 2002 Oct 8. Proc Natl Acad Sci U S A. 2002. PMID: 12374859 Free PMC article.
-
T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model.Biophys J. 2001 Nov;81(5):2547-57. doi: 10.1016/S0006-3495(01)75899-7. Biophys J. 2001. PMID: 11606269 Free PMC article.
-
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.Br J Cancer. 2002 Apr 22;86(8):1336-42. doi: 10.1038/sj.bjc.6600223. Br J Cancer. 2002. PMID: 11953895 Free PMC article.
-
Early T-cell activation biophysics.HFSP J. 2009 Dec;3(6):401-11. doi: 10.2976/1.3254098. Epub 2009 Nov 10. HFSP J. 2009. PMID: 20514131 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials